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Kieckbusch et al. show that a key
leukocyte signaling molecule, p110d,
regulates uterine immune cells. Genetic
p110d inactivation in mice reduced NK
but increased macrophage function, thus
impeding uterine arterial remodeling and
enhancing local inflammation during
pregnancy. Imbalanced adaptation of
maternal immune cells curtailed fetal
development and increased perinatal
morbidity.
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Maternal immune cells are an integral part of repro-
duction,but how theymight causepregnancycompli-
cations remains elusive. Macrophages and their dual
function in inflammation and tissue repair are thought
to play key yet undefined roles. Altered perinatal
growth underpins adult morbidity, and natural killer
(NK) cells may sustain fetal growth by establishing
the placental blood supply. Using a mouse model of
genetic inactivation of PI3K p110d, a key intracellular
signalingmolecule in leukocytes,we show that p110d
regulates macrophage dynamics and NK-cell-medi-
ated arterial remodeling. The uterus of dams with
inactive p110d had decreased IFN-g and MHC class
IIlow macrophages but enhanced IL-6. Poor vascular
remodeling and a pro-inflammatory uterine milieu re-
sulted in fetal death or growth retardation. Our results
provide one mechanism that explains how imbal-
anced adaptations of maternal innate immune cells
to gestation affect offspring well-being with conse-
quence perinatally and possibly into adulthood.
INTRODUCTION
Class I phosphoinositide 3-kinases (PI3K) convert phosphatidy-
linositol-(4,5)-phosphate to phosphatidylinositol-(3,4,5)-phos-
phate (PIP3). PIP3 acts as a second messenger by recruiting
proteins to the plasma membrane, where they activate signaling
pathways that promote proliferation, survival, differentiation, and
chemotaxis (Okkenhaug, 2013). PI3K can be subdivided into
class I A and I B based on structural similarity. Class I A PI3K
form heterodimers of p85 regulatory subunits and one of three
isoforms of the catalytical p110 subunit (p110a, p110b, and
p110d). While p110a and p110b are ubiquitously expressed, in
mice, p110d expression is low or absent in most cell types but
high in leukocytes (Vanhaesebroeck et al., 1997).
PI3K p110d is a key mediator of natural killer (NK) cell matu-
ration and function, and absence of p110d signaling leads to
reduced cytokine release, aberrant maturation, and incorrect
trafficking to peripheral organs, including the uterus during
pregnancy (Guo et al., 2008; Kim et al., 2007; SaudemontCell Repet al., 2009; Tassi et al., 2007). In macrophages and other
myeloid cells, the PI3K pathway has two opposing roles.
While it promotes tissue infiltration and signal transduction for
cytokine secretion in the early phases of inflammation, PI3K
signaling also provides negative feedback inhibition and is
thus involved in the resolution of inflammation and the preven-
tion of ‘‘collateral damage’’ (Fukao and Koyasu, 2003; G€unzl
et al., 2010). As a result, inactivation of p110d leads to enhanced
responses downstream of Toll-like receptors (Aksoy et al., 2012;
Uno et al., 2010), increased production of pro-inflammatory cy-
tokines such as interleukin-6 (IL-6) (Liu et al., 2009), upregulation
of macrophage activation markers such as CD86 and major
histocompatibility complex (MHC) class II in vitro, and chronic
inflammation (Uno et al., 2010). Conversely, deletion of PTEN,
which acts antagonistically to the PI3K pathway by degrading
PIP3, diminishes macrophage inflammatory responses (Sahin
et al., 2014).
In mice, blastocyst implantation provokes a localized, pro-
gesterone-driven tissue reaction that causes stromal cells to
proliferate extensively and form decidual cells (decidualization)
(Dey et al., 2004). While the decidua grows, the vasculature
feeding toward the developing fetoplacental unit changes
from its conventional, arterial phenotype characterized by a
thick smooth muscle wall to high-capacity, low-resistance ves-
sels. Both processes are disrupted in mice lacking either NK
cells (Ashkar et al., 2000; Barber and Pollard, 2003) or inter-
feron-g (IFN-g) signaling (Ashkar and Croy, 1999), establishing
a key role for IFN-g produced by uterine NK (uNK) cells in repro-
duction. Uterine macrophages are a specialized myeloid subset
whose spatial distribution and population dynamics are regu-
lated by local colony stimulating factor (CSF)-1 signaling: mac-
rophages and CSF-1 are highly abundant in the myometrium
but relatively sparse in the decidua (Collins et al., 2009; Tagliani
et al., 2011). CSF-1 signaling also blocks macrophage matura-
tion at the transition from MHC class IIlow to MHC class IIhigh
cells (Tagliani et al., 2011). Little is known about the endoge-
nous cues that activate or inhibit uterine macrophages, but
excessive activation by exogenous stimuli is usually prevented
(Erlebacher, 2013). Unrestrained macrophage activation can
result in fetal mortality (Haddad et al., 1995; Robertson et al.,
2006).
The selective expression of p110d in leukocytes hasmade it an
attractive pharmacological target to treat hematological malig-
nancies and reduce unwanted immune responses in the contextorts 13, 2817–2828, December 29, 2015 ª2015 The Authors 2817
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Figure 1. Maternal PI3K p110d Inactivation
Affects IFN-g Production In Utero
(A) Recovered live cells per implantation site after
enzymatic digestion.
(B) Representative density plot of CD3 NK1.1+
cells as a fraction of leukocytes, gated on live CD45+
singlets.
(C) Quantification of recovered live CD3 NK1.1+
cells as % of leukocytes (gated as in B).
(D) Representative density plot of CD49a and DX5
expression in utero, gated on live CD45+ CD3
NK1.1+ cells.
(E) Ratios of CD49a/DX5-positive cells.
(F) Assessment of IFN-g in uterine tissue; n = 5 mice
per group.
(G) Quantification of Il15 expression in non-he-
matopoietic cells; n = 3 mice per group.
(H–K) Assessment of uNK cells in non-pregnant
mice: (H) frequency of NK1.1+ cells, (I) relative
contribution of CD49a+ NK and cNK, and their ability
to proliferate (J and K). n = 6 mice per group from
two independent experiments. Indicated is the
maternal genotype. All females were mated with
B6 males. p values are from unpaired, two-tailed
Student’s t tests.
Data in (A), (C), and (E–K) are means ± SEM; n = 6–7
mice from five independent experiments. See also
Figures S1 and S2.of autoimmunity and allergy (Rodon et al., 2013). Maternal
immune adaptations during pregnancy are instrumental for the
development of the growing fetus (Erlebacher, 2013; Moffett
and Colucci, 2014). We used transgenic knockin mice carrying
a kinase-dead point mutation in the gene coding for p110d
(dD910A) as a genetic model for inactivation of the p110d pathway
in order to investigate the effects of unbalanced maternal im-
mune responses during gestation. We show that maternal
p110d signaling is required for the normal production of IFN-g
in the gravid uterus and the associated NK-driven remodeling
of the maternal vasculature feeding toward the fetoplacental
unit. Fetuses carried by dD910A females were growth retarded
and showed increased mortality in utero. Underpinning this
fetal demise was a local inflammatory response characterized
by increased abundance of MHC class IIhigh expressing macro-
phages and IL-6. After birth, the surviving offspring displayed
rapid catch-up growth. These findings demonstrate that
maternal p110d signaling is required for reproductive fitness
and stress the importance of correct immune regulation during
gestation.2818 Cell Reports 13, 2817–2828, December 29, 2015 ª2015 The AuthorsRESULTS
Maternal PI3K p110d Inactivation
Affects IFN-g Production In Utero
In mice, uNK cell-derived IFN-g is key for
the vascular changes the gravid uterus
needs to undergo to ensure ample and
constant blood supply to the fetoplacental
unit (Ashkar and Croy, 2001; Ashkar et al.,
2000; Kieckbusch et al., 2014). We and
others have previously shown that PI3Kp110d regulates NK cell development, function, and trafficking
(Guo et al., 2008; Kim et al., 2007; Saudemont et al., 2009; Tassi
et al., 2007). The role of this isoform in reproductive immunology,
however, has not yet been well characterized.
NK cells from dD910A mice are known to have a reduced migra-
tory potential to the pregnant uterus in a competition situation
with wild-type NK cells (Saudemont et al., 2009). We therefore
hypothesized that there may be NK cell abnormalities in dD910A
mice that could underpin pregnancy complications and set out
to investigate the effect of p110d inactivation in this context.
dD910A females displayed reduced overall cellularity during preg-
nancy (Figure 1A), but the abundance of NK1.1+ CD3 cells
among CD45+ cells was comparable in dD910A and B6 controls
(Figures 1B and 1C). Recently, NK cells found in peripheral tis-
sues, including the uterus, have been distinguished into ‘‘tissue
resident’’ and ‘‘conventional’’ NK (cNK) cells, which migrate to
these organs (Sojka et al., 2014). Tissue resident NK cells display
low or no expression of DX5 (CD49b) but are instead CD49a+.
These resident cells would not be expected to be affected to
the same degree by impaired NK trafficking in dD910A mice and
thus blur the picture. Accordingly, we delineated NK1.1+ CD3
cells into CD49a+ cells (mainly comprising tissue-resident cells)
and cNK subsets to resolve their relative frequencies in dD910A
mice at midgestation (Figures 1D and 1E). The ratio of both cell
population was similar in both strains, further demonstrating
that the decreased migratory potential of NK cells from dD910A
mice does not translate into overall changes in NK abundance
in utero. uNK cells require IL-15 (Barber and Pollard, 2003) and
produce >90% of IFN-g in uterine tissues, and this cytokine is
both necessary and sufficient to induce complete vascular re-
modeling (Ashkar and Croy, 1999, 2001; Ashkar et al., 2000).
Reduced activation of uNK cell subsets leads to decreased
uNK IFN-g production (Kieckbusch et al., 2014), and the PI3K
p110d/Akt pathway is known to be crucial for the normal release
of IFN-g by NK cells (Guo et al., 2008; Kim et al., 2007). In line
with this reported evidence for peripheral NK cells, we found a
marked reduction of IFN-g in decidua and MLAp (myometrial
lymphoid aggregate of pregnancy) by >35% (Figure 1F;
233.6 pg/g ± 14.79 versus 145 pg/g ± 8.24). We found no differ-
ence in Il15 expression by non-hematopoietic cells at the
maternal fetal interface (Figure 1G). The uNK cell maturation pro-
file differs from that of peripheral NK cells (Kieckbusch et al.,
2014), and insufficient maturation might underpin reduced levels
of tissue IFN-g. However, we could not find absence of uNK cell
maturation in dD910A females (Figure S1). PI3K p110d is known to
be important for T and B cell development and function (Bilancio
et al., 2006; Okkenhaug et al., 2002; Patton et al., 2006; Putz
et al., 2012; Soond et al., 2010). No difference in the cellularity
of any lymphocyte subset investigated was found (Figure S2).
To investigate the possibility of an NK defect in these mice
further, we extended our evaluation to non-pregnant mice. While
we found no difference in the overall size of the NK compartment
(Figure 1H), CD49a+ NK were overrepresented in non-pregnant
dD910A mice (Figure 1I). Lack of p110d signaling did not affect
the potential of either uNK cell subset to proliferate, as both dis-
played indistinguishable levels of Ki-67 positivity (Figures 1J and
1K). Together, these data demonstrate the importance of PI3K
p110d in uNK cell IFN-g production but show that its function
is dispensable for maintaining normal uterine lymphocyte cellu-
larity during pregnancy.
Maternal p110d Inactivation Impedes Normal
Decidualization and Arterial Remodeling
In mice, decidualization is accompanied by the establishment of
a highly organized lymphoid structure adjacent to the decidua
(MLAp) and distal to the invading trophoblast. Both decidualiza-
tion and MLAp growth are impaired in the absence of uNK cells
(Ashkar and Croy, 2001; Barber and Pollard, 2003; Guimond
et al., 1997). Visual examination of H&E-treated sections showed
both smaller decidual and MLAp areas on midsagittal uterine
sections, indicating impaired decidualization andmyometrial ab-
normalities in dD910A females (Figure 2A).Quantification of the vol-
umes of both compartments showed a reduction in size (Figures
2B and 2C), which correlated with the observed reduced overall
cellularity (Figure 1A). Strikingly, implantation sites from dD910A fe-
malesalsodisplayedamarked reduction invessel size (Figure2D)
and in the ratio between vessel and lumen areas, which is amea-
sure of arterial remodeling (Figure 2E). Both are NK cell-drivenCell Repprocesses mediated by IFN-g (Ashkar et al., 2000). This was
confirmedby visualizing smoothmuscle actin in the decidua (Fig-
ure 2F).While the thickmusclewall surrounding the spiral arteries
had almost completely disappeared in controls, it was still prom-
inent in dD910A females at gestational day 9.5 (gd9.5). To ascertain
that this phenotype was leukocyte-specific, we evaluated
expression of thepik3cd gene (which codes for p110d) in non-he-
matopoietic cells at the maternal-fetal interface. CD45- cells
showed very low levels of transcripts close to the detection
threshold and comparable to those in the mouse fibroblast cell
line NIH 3T3 (Figure 2G) that was used as a negative control
due to its reported low pik3cd expression (Kok et al., 2009).
Taken together, these results demonstrate that maternal
p110d signaling in leukocytes is important for normal decidual
and myometrial development during pregnancy and that it is
essential for arterial remodeling and a normal blood supply to
the fetoplacental unit.
Maternal p110d Is Required for Normal Fetal Growth
Next, we investigated the downstream effects of the suboptimal
intrauterine environment on the developing fetuses. Fetuses car-
ried by dD910A females showed significantly lower weights, which
was detectable as early as gd14.5. This reduction in fetal growth
resulted in offspring that was >13% smaller than in control preg-
nancies just before term (1.227 g ± 0.006 g versus 1.064 g ±
0.015 g at gd18.5). Reduction of mean fetal weight at gd18.5
was due to differences in weight distribution (Figure 3B). Strik-
ingly, there was a >15-fold increase in growth-retarded fetuses
defined as within or below the fifth percentile of B6 controls (Fig-
ure 3C). Placental growth was very similar in conceptuses from
dD910A females and B6 controls apart from a subtle increase in
placental weight at gd16.5 (Figure 3D). Accordingly, absence
of maternal p110d signaling lead to a reduction in the capacity
of placentas of similar size to support the same fetal growth, sug-
gesting reduced placental efficiency throughout gestation
(Figure 3E). In these experiments, both dD910A females and
control B6 females were mated with B6males, resulting in heter-
ozygous dD910A offspring (dD910A 3 B6)F1 in one group and
homozygous wild-type (WT) offspring in the other. To exclude
a possible gene dose effect caused by only one functional
copy in (dD910A 3 B6)F1 fetuses rather than a maternal effect of
p110d inactivation, we repeated these experiments using
the reverse cross (B6 females mated with dD910A males) to
produce isogenic fetuses in samples and controls (shown
as ‘‘maternal 3 paternal’’ genotype, (dD910A 3 B6)F1 and (B6 3
dD910A)F1). Figure 3F shows that isogenic heterozygous fetuses
(dD910A/WT) showed different fetal weights at gd18.5 that
depended on whether or not maternal PI3K p110d signaling
was absent, thus strongly suggesting a maternal rather than a
fetal phenotype in these matings. Potential gene dose effects
may also affect the placenta, which has the same genotype as
its fetus. To this end, histological examination showed no overt
differences in the fetomaternal exchange area (labyrinth zone,
Figures 3G and 3H), but a slight increase in the size of the
junctional zone that borders this area was observed (data not
shown). To exclude differences in maternal nutrient allocation
that might affect fetal growth in dD910A mothers, we also as-




Figure 2. Maternal p110d Inactivation Im-
pedes Normal Decidualization and Arterial
Remodeling
(A) H&E staining of gd9.5 uterine tissue shows
smaller MLAp (top) and decidual (bottom) areas in
dD910A females. Scale bars represent 100 mm (top)
and 500 mm (bottom). Dashed line demarcates the
boundaries between MLAp and surrounding tis-
sues.
(B and C) Volume estimation of decidual and MLAp
compartments using the Cavalieri method.
(D and E) Quantification of vessel size (D) and
vessel/lumen ratio as readout for vascular remod-
eling (E). Data are representative of four litters with
n = 13–14 implantation sites.
(F) Smooth muscle actin staining shows incomplete
vascular remodeling in the absence of maternal
p110d signaling. Scale bar, 100 mm. Indicated is the
maternal genotype and all females were mated with
B6 males. p values for the effect of maternal geno-
type from a mixed model approach, taking the
clustering of observations by litter into account.
(G) Relative expression of the gene coding for p110d
(pik3cd) in non hematopoietic CD45 cells and NK
cells (positive control) as well as the NIH 3T3 fibro-
blast cell line (negative control). n = 3 mice per
group. All data are presented as means ± SEM.
MLAp, mesometrial lymphoid aggregate of preg-
nancy.found a subtle decrease in non-fasting glucose levels at the end
of gestation that was pregnancy specific, as we found non-preg-
nant dD910A to have slightly elevated glucose levels (Figure 3I). No
significant differences were observed in the levels of triglycer-
ides or cholesterol (data not shown). Taken together, these
data show that maternal p110d is crucial for normal fetal growth
in utero.
Fetal Death and Accelerated Postpartum Growth in the
Absence of Maternal p110d Signaling
To further investigate the effect of maternal p110d inactivation on
reproductive success, we assessed the litter sizes from dD910A
females (Figure 4A). The number of viable conceptuses remained
similar up until midgestation, demonstrating that maternal p110d
signaling is dispensable for implantation. This changed in the
second half of gestation, where >35% of fetuses in dD910A fe-
males died (litter sizes were 7.76 ± 0.2 in wild-type females2820 Cell Reports 13, 2817–2828, December 29, 2015 ª2015 The Authorsversus 5 ± 0.38 in dD910A females), further
emphasizing the detrimental effect of
maternal p110d inactivation for fetal well-
being. Litter sizes in the reverse cross
were normal, demonstrating that absence
of maternal p110d signaling, rather than a
fetal effect of the heterozygous dD910A
mutation, was responsible for this (Fig-
ure 4B). Importantly, Rag2/Il2rg/
(Rag2/gc/) mice that lack all lympho-
cytes including NK cells show a reduction
in fetal growth (Croy et al., 2011; Kieck-
busch et al., 2014) but no decrease inthe number of viable implantation sites (Figure 4B). This sug-
gested that while the defect in NK cells described here may be
sufficient to explain the reduction in fetal weight and arterial re-
modeling, it was likely that other, non-lymphoid cells were also
affected by maternal p110d inactivation and contributed to the
fetal demise.
Low birth weight predisposes to adult diseases such as
metabolic disease, cardiovascular disease, and cancer (Barker,
2004). Excessive growth postpartum (‘‘catch-up’’ growth)
following fetal growth restriction is associated with additional
risk factors, including decreased cognitive functions and short
lifespan (Fisher et al., 2006; Geiger et al., 2012; Ozanne and
Hales, 2004). To investigate if maternal p110d inactivation
might contribute to this increased risk, we followed the growth
trajectory of (dD910A 3 B6)F1 and (B6 3 dD910A)F1 offspring.
Pup weights from both crosses were indistinguishable starting







Figure 3. Maternal p110d Is Required for
Normal Fetal Growth
(A) Fetal weights of conceptuses from either B6 of
dD910A females mated with B6 males (means ±
SEM). Data are from 9–14 litters per maternal ge-
notype per time point.
(B and C) Analysis of the distribution of fetuses
fromB6 of dD910A females. Data are from of 13 or 14
litters, dashed line shows fitted Gaussian distribu-
tion. p value from Fisher’s exact test comparing the
fraction of growth restricted fetuses (weights within
or below the fifth percentile of controls).
(D) Placental weights of conceptuses from either
B6 of dD910A females mated with B6 males (means
± SEM). Data are from 9–14 litters per maternal
genotype per time point.
(E) Ratio of fetal/placental weight from (B) and (D)
showing placental efficiency.
(F) Comparison of fetal weight between isogenic
fetuses from the depicted crosses normalized to B6
controls (mean ± SEM). Data from 4–14 litters.
(A, D, E, and F) p values for the effect of maternal
genotype from a mixed model approach taking the
clustering of observations by litter into account.
(G) H&E stainings of placentas at gd18.5 show no
overt differences in the maternal/fetal exchange
region (labyrinth, dashed line). Scale bar, 1 mm.
(H) Quantification of cross-sectional area of
labyrinth zone in gd18.5 placentas. Data repre-
sentative of 12 placentas from four litters per cross
(means ± SEM).
(I) Non-fasting blood glucose levels prior to and
during pregnancy.
Data are means ± SEM (H and I); p values are from
unpaired, two-tailed Student’s t tests.demonstrating accelerated growth in the sensitive postnatal
period.
In order to assess if the observed phenotype was restricted to
primiparous females, we obtained breeding records from two
animal facilities (Figures 4D, 4E, and S3). We found that maternal
p110d signaling was essential for normal litter sizes regardless of
parity. This finding was reproduced also in OT-II Rag2/dD910A
mice which lack B cells and are incapable of generating fetal-
specific T cells (Figure 4F), suggesting that dysregulation in
these cells does not contribute to increased fetal loss. Together,
these data show that maternal p110d inactivation affects fetal
well-being.Cell Reports 13, 2817–2828, DeMaternal p110d Signaling Prevents
Uterine Inflammation
As the NK phenotype could explain differ-
ences in fetal growth, but not in litter size,
we extended our focus to myeloid cells. A
gating strategy adapted from Tagliani
et al. (2011) was used to identify macro-
phages, neutrophils, Ly6Chigh monocytes
(a precursor to uterine macrophages),
and dendritic cells (DCs) (which are re-
cruited to the uterus by uterine macro-phages; Figure 5A). We found that all myeloid subsets except
neutrophils were significantly underrepresented during preg-
nancy (Figure 5B). Using immunohistochemistry, we confirmed
that the abundance of F4/80+ was indeed lower in both decidua
and MLAp of dD910A females around midgestation (Figure 5C).
Uterine macrophages can be grouped into two subsets based
on their expression of MHC class II (Tagliani et al., 2011): a
subset that expresses low levels of MHC class II (MHC-IIlow),
which has been reported to have higher mRNA levels of genes
associated with alternatively activated (M2) macrophages,
and a second subset that expresses high levels of MHC class
II (MHC-IIhigh) and has a transcription profile of genes morecember 29, 2015 ª2015 The Authors 2821
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Figure 4. Fetal Death and Accelerated Post-
partum Growth in the Absence of Maternal
p110d Signaling
(A) Assessment of the number of viable implan-
tation sites in litters from females of the depicted
genotype mated with B6 males before and after
midgestation; n = 17–29 litters.
(B) Assessment of the number of viable implanta-
tion sites of the indicated crosses; n = 5–14 litters
per group.
(C) Comparison of isogenic offspring from matings
with maternal or paternal p110d inactivation. Data
are from six to eight litters per parental cross.
(D) Summary of breeding records showing the mean
litter size of breeding females at birth (indicated is the
maternal genotype).Dataaremeans±SEM;pvalues
are from unpaired, two-tailed Student’s t tests.
(E) Quantification of the fraction of multiparous
breeders with a mean litter size <5. p values are
from Fisher’s exact test.
(F) Assessment of offspring survival in dD910A mice
lacking B cells and T cells that can recognize
fetal antigens; n = 31–60 litters per group. Data
are means ± SEM; p values are from unpaired,
two-tailed Student’s t tests.
Data in (D) and (E) are representative of 25 and
471 breeders, respectively, corresponding to 102–
1,055 litters.
See also Figure S3.associated with the M1 type of macrophages. Given the striking
reduction in macrophage abundance, we investigated their
phenotype further. In dD910A females, the MHC-IIhigh subset
was relatively overrepresented among macrophages (Figures
5D and 5E), suggesting an imbalance toward a more inflamma-
tory uterine milieu in these mice during pregnancy. In contrast,
no subset imbalance was seen for DCs (CD11bhigh versus
CD11blow) or monocytes (MHC-II+ versus MHC-II; Figures 5F
and 5G). Apart from IFN-g, uNK cells can also produce other
immunomodulatory factors, including CSF-1, a key cytokine for
uterine macrophage population dynamics, so that unbalanced
uNK activation could potentially be responsible for the macro-
phage phenotype. To explore this possibility, we assessed the
expression of csf1 and ccl5 (whose gene product is RANTES
that could regulate uNK cell migration). For csf1, we found the
highest relative amount of mRNA in non-hematopoietic cells,
but at similar levels in both strains across cell types (Figure 5H).
Expression of Ccl5 was also similar between strains, but uNK
cells had higher expression than CD45 cells (Figure 5I). To
further investigate a possible regulatory role of uNK or other
lymphoid cells on macrophages, we also assessed the pheno-
type of myeloid cells in Rag2/gc/ mice which showed
neither disruption of macrophage numbers nor reduction in DC
or monocytes despite the total absence of NK cells (Figures 5J
and 5K). We did, however, find increased numbers of uterine
neutrophils, thus excluding the possibility that an increase of
these cells by itself can cause fetal loss. Together, these results
demonstrate changes in uterine myeloid cells including a more
inflammatory macrophage phenotype in the absence of p110d
signaling. The results also suggest that these changes are not
due to NK cell dysregulation.2822 Cell Reports 13, 2817–2828, December 29, 2015 ª2015 The AuLocal, but Not Systemic, Inflammation Underpins Fetal
Growth Restriction and Increased Fetal Mortality
The PI3K pathway is known to be important for the resolution of
inflammation mediated by myeloid cells (G€unzl et al., 2010),
and the p110d subunit of PI3K has been shown to induce a
negative feedback mechanism that dampens macrophage
activation downstream of Toll-like receptors (Aksoy et al.,
2012). The overrepresentation of MHC-IIhigh macrophages
raised the question as to whether an increased inflammatory
response could be responsible for the increase in fetal loss. To
test whether changes in the relative abundance of macrophage
subsets translate into a more potent inflammatory response,
we assessed macrophage effector functions (IL-6 production
and CD107a surface exposure as a proxy for degranulation).
Macrophages in dD910A mice showed a significantly higher
responsiveness even after overnight culture (Figures 6A and
6B). IL-6 has been reported to be involved in fetal loss (Zenclus-
sen et al., 2003), and following its increased production by uter-
ine macrophages in the absence of p110d signaling, we wanted
to directly assess whether this correlated with overall higher
levels of this cytokine in decidua and myometrium. We found a
significant increase in IL-6 levels in situ (Figure 6C), but no
change in IL-10 (Figure 6D), which is associated with an anti-in-
flammatory response. Tissue levels of tumor necrosis factor
(TNF) and IL-1b were below the detection threshold in both
strains (data not shown). Together, these results show a dysre-
gulation of macrophage dynamics and function that was associ-
ated with upregulation of IL-6, suggesting a more inflammatory
intrauterine environment.
dD910A mice are known to develop mild inflammatory bowel
syndrome in adulthood (Okkenhaug et al., 2002). Accordingly,thors
we tested if the inflammatory phenotype observed in utero was
only seen in the local environment or due to possible systemic
inflammation and unrelated to pregnancy. To this end, we found
similar serum levels of IL-6, TNF, and IL-10 in the second half of
gestation, clearly showing that the inflammatory uterine milieu is
restricted locally and not associated with acute systemic inflam-
mation during pregnancy (Figure 6). We did find increased IL-6
levels in one out of six females at gd14.5 and one out of seven
females at gd18.5. However, these did not correlate with in-
creases in TNF, and in order to be causally linked to the pheno-
type described here, we would expect all females to show
increases in IL-6 at the end of gestation (gd18.5). We also as-
sessed serum IL-1b with very low overall abundance and a
similar number of samples below the detection threshold of 0.3
pg/ml in both strains (data not shown). Progesterone withdrawal
is a potent inducer of fetal loss (Yang et al., 2000). Lastly, to
investigate whether reduced progesterone levels might
contribute to the phenotype in dD910A females, we evaluated
the levels of this hormone in the serum late in gestation. We
found no evidence for a reduction in progesterone due to
p110d inactivation but instead found a small but signifi-
cant increase (Figure 6H). Together, these data show a height-
ened inflammatory environment in utero in the absence of sys-
temic inflammation or progesterone dysregulation.
DISCUSSION
Little is known about the mechanisms that orchestrate the dy-
namic changes that uterine innate immune cells undergo during
gestation. Our results identify a key role for maternal PI3K p110d
signaling in the immune regulation during pregnancy. This
isoform is absent in most tissues but highly expressed in leuko-
cytes (Vanhaesebroeck et al., 1997). Due to its function in
many immune cells and the importance of leukocytes for suc-
cessful pregnancy, the mechanisms by which p110d signaling
impacts reproductive success are multifactorial. Maternal
p110d inactivation affected the outcome of pregnancy through
two pathways: one mediated by poor uNK function leading
to reduced arterial remodeling and fetal growth restriction
and one characterized by a heightened inflammatory uterine
milieu underpinning increased fetal mortality (Figure S4).
PI3K p110d has been implicated in smaller litter sizes in a
previous study using knockout mice on a 129 background
(Li et al., 2013). In that study, the authors suggested that
this was due to differences in ovarian hormone responsive-
ness of these pik3cd/ mice. The study of class IA PI3K is
complicated by the fact that the absence of one subunit af-
fects the expression levels of other subunits (Okkenhaug and
Vanhaesebroeck, 2001), which is not the case for the ki-
nase-dead mutation in dD910A mice (Okkenhaug et al., 2002).
Our results demonstrate that maternal p110d does not alter
the amount of implanted blastocysts that gestate
to midpregnancy but rather fetal growth and survival after
this time point.
In non-pregnant mice, we found an overrepresentation of
CD49a+ uNK cells. Based on our previous work that showed
defective migration of dD910A NK cells to the uterus upon transfer
to pregnant mice (Saudemont et al., 2009), we hypothesized toCell Repfind decreased numbers of cNK cells in pregnant dD910A mice,
but both their fraction and total number in implantation sites at
midgestation were normal in dD910A mice. Moreover, transcripts
of genes encoding the key cytokine IL-15 and the chemokine
CCL5 were normal in dD910A mice. Our results presented here
suggest that compensatory mechanisms other than overt dif-
ferences in proliferation or migration are in place that lead to
similar uNK cell abundance in both strains.
While we were unable to detect a clear difference in the uter-
ine lymphocyte profile of dD910A mice during pregnancy, we did
notice an overall higher variance in some leukocyte subsets
compared to B6 controls (e.g., T cells in Figure S2 and neutro-
phils in Figure 5B). The reason for this is unclear, but it might be
due to the fact that the results are generated by pooling implan-
tation sites from individual mice, in which the observed pheno-
type may be at different stages. Another factor is that we used
pooled cell suspensions from decidua and myometrium (MLAp)
to evaluate overall leukocyte dynamics in utero. This might
obscure smaller differences that occur in one compartment,
but not in the other, especially given their known differences
in leukocyte composition (Doisne et al., 2015; Tagliani et al.,
2011).
PI3K p110d has a critical role for B and T cell function,
including regulatory T (Treg) cells (Ali et al., 2014; Liu et al.,
2009; Okkenhaug et al., 2002; Patton et al., 2006), and it is
thus possible that Treg cells are less effective at controlling
effector responses in the uterus of dD910A mice. While fetal loss
in dD910A females mated with syngeneic males was independent
of adaptive B or T cells capable of responding to fetal antigens,
we would hypothesize that p110d inactivation in allogeneic
matings may be even more detrimental to fetal survival, as
Treg function is crucial in this setting (Rowe et al., 2012; Sam-
stein et al., 2012).
CSF-1 is a key player for orchestrating distribution and popu-
lation dynamics of macrophages as well as DCs in utero, and
mice lacking CSF-1 show mildly reduced litter sizes (Pollard
et al., 1991; Tagliani et al., 2011). High MHC class II expression
in macrophages correlates with a transcription profile of classi-
cally activated (M1) cells that are associated with inflammatory
responses, whereas low class II expression is found on cells
that express genes observed in alternatively activated macro-
phages (M2 group) that are involved in tissue remodeling and
angiogenesis (Murray et al., 2014). The conversion of these
M2-like cells to M1-like cells is normally blocked by CSF-1
signaling. Because p110d is the dominant PI3K isoform down-
stream of CSF-1 receptor in primary macrophages (Papakon-
stanti et al., 2008), it is conceivable that dampened CSF-1
signaling may contribute to the altered macrophage dynamics
and the relative abundance of cells highly expressing MHC class
II in dD910A mice. It has been speculated that MHC-IIhigh and
MHC-IIlow subsets resemble CD209 and CD209+ macrophage
subsets found in first trimester human endometrium based on
similarities in gene expression (Erlebacher, 2013). In macro-
phages and other myeloid cells, p110d signaling is known to
be crucial for the resolution of inflammation (Aksoy et al., 2012;
Fukao and Koyasu, 2003; G€unzl et al., 2010; Liu et al., 2009;
Uno et al., 2010). This might explain the relative overrepresenta-
tion of macrophages with amore inflammatory phenotype; theseorts 13, 2817–2828, December 29, 2015 ª2015 The Authors 2823
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Figure 6. Local, but Not Systemic, Inflamma-
tion Underpins Fetal Growth Restriction and
Demise
(A–D) Flow cytometry staining for intracellular IL-6 (A)
and surface CD107a (B) on macrophages (adherent
CD45+ CD11b+ F4/80+ cells) at gd10.5 after overnight
culture. Data are from three independent experi-
ments; n = 4 mice per group. (C) Quantification of
tissue IL-6 and (D) IL-10; n = 5 mice per group.
(E–H) Assessment of serum IL-6 (E), TNF (F), IL-10 (G),
and progesterone (H); n = 5–7 per group. Data are
means ± SEM; p values are from an unpaired, two-
tailed Student’s t test.cells need to receive their physiological cues in utero to function
correctly. In the absence of p110d signaling, this activation be-
comes dysregulated, and instead of switching to their physiolog-Figure 5. Maternal p110d Signaling Prevents Uterine Inflammation
(A) Gating strategy for identifying macrophages, dendritic cells (DC), Ly6Chigh monocytes, and neutrophil
(B) Fold change of absolute cell numbers per implantation site of the indicated populations in dD910A fema
p values compare the cell number in dD910A with the mean of controls.
(C) Histological examination of abundance of F4/80+ cells in MLAp (top) and decidua basalis (botto
bars, 100 mm.
(D) Representative density plots showing MHC-II expression of uterine macrophages gated as in (A).
(E) Relative abundance of MHC class IIhigh versus MHC class IIlow macrophage populations.
(F) Relative abundance of CD11bhigh and CD11blow DC subsets.
(G) Relative abundance ofMHC class II+ versusMHC class II Ly6Chigh monocyte populations. Data are rep
group.
(H and I) Relative mRNA quantification for Csf1 (H) and Ccl5 (I); n = 3 mice per group.
(J) Fold change of absolute cell numbers per implantation site of the indicated populations in Rag2/gc/
the cell number in Rag2/gc/ with the mean of controls.
(K) Relative abundance of MHC class IIhigh versus MHC class IIlow macrophage populations. Data are mean
unpaired, two-tailed Student’s t test.
Cell Reports 13, 2817–2828,ical role in tissue remodeling, macrophages
sustain persistent inflammation.
Excessive immune activation has long
been known to compromise pregnancy
success and activation of the innate
immune system by pathogen-derived
danger signals can jeopardize fetal survival
(Parant and Chedid, 1964; Xu et al., 2000).
Although the underlying mechanisms are
still not fully understood, it seems clear
that the tissue damage mediated by infil-
trating neutrophils and activated macro-
phages is not conducive to a uterine
microenvironment capable of promoting
adequate fetal growth. Pregnancy is not
accompanied by general immunosuppres-
sion (Kourtis et al., 2014), however, and it
is becoming increasingly clear that suc-
cessful pregnancies involve a fine balance
between activating those parts of the im-
mune system involved in trophic functions
(uNK-mediated arterial remodeling, macro-
phage involvement in tissue remodeling)
and those components that are involved
in host defense (Colucci and Kieckbusch,
2015). To this end, great care must betakenwhen it comes to clinical interventions with the aim of inter-
fering with immune responses during gestation, as the spatio-
temporal role of each leukocyte subset is far from understood.s at gd10.5.
les compared to B6 controls. Data are means ± SEM;
m) of sections from gd9.5 pregnant females. Scale
resentative of five experiments using n = 6–7mice per
females compared to B6 controls. p values compare
s ± SEM; n = 4–6mice per group. p values are from an
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Isoform-specific small molecule inhibitors for p110d are now
in clinical trials. dD910A mice model long-term p110d inhibition,
and our results suggest that such long-term inhibition may
best be avoided during pregnancy.
The traditional model for inflammation-mediated fetal demise
is injection with Toll-like receptor agonists such as poly(I:C) or
lipopolysaccharide. This also triggers systemic immune system
activation (Cotechini et al., 2014; Thaxton et al., 2013; Zhao
et al., 2015). In our study, we observed local and spontaneous
inflammation in utero with physiological levels of inflammatory
cytokines in the periphery throughout gestation. This suggests
that dD910A mice are indeed a good model to study the effects
of uterine inflammation during pregnancy in greater detail, as it
allows for complete dissociation of systemic and local inflamma-
tion. In conclusion, our results emphasize the complexity of
maternal immune responses during pregnancy. This strengthens
the notion that clinical interventions with the aim of dampening
maternal immune responses do not have a scientific basis (Mof-
fett and Colucci, 2014). Rather, multiple leukocyte subsets need
to exert their functions in a balanced way.
EXPERIMENTAL PROCEDURES
Mice
All animal experiments were approved by the University of Cambridge Ethical
Review Panel and carried out in accordance with Home Office Project License
PPL 70-8222. C57BL/6 (B6)mice were purchased fromCharles River UK.Mice
with a kinase-dead mutation in the gene coding for PI3K p110d (dD910A) have
been described before (Okkenhaug et al., 2002) and were backcrossed on a
B6 background for >12 generations. OT-II Rag2/ dD910A (Ali et al., 2014)
and alymphoid Rag2/II2rg/ (Rag2/gc/) (Colucci et al., 1999) mice
on B6 background have been described before. Mice were 8–12 weeks of
age and showed no signs of colitis. For pregnancy experiments, female
mice were randomly introduced to males and the timing of conception was
determined by detection of a copulation plug representing gd0.5.
Flow Cytometry
Cell suspensions of uterine tissues were prepared using either mechanical
dissociation followed by centrifugation through a Lympholyte M (Cedarlane)
gradient according to the manufacturers recommendations or by enzymatic
digestion using Liberase TM (Roche) as described previously (Collins et al.,
2009). Cells were typed using fluorochrome-conjugated antibodies with spec-
ificity for CD45 (30-F11), NK1.1 (PK138), CD11b (M1/70), CD27 (LG.3A10),
CD49a (HMa1), CD49b (DX5), KLRG1 (MAFA), Ly6C (HK1.4), Gr-1 (RB6-
8C5), I-A/I-E (M5/114.15.2), F4/80 (BM8), CD11c (N418), CD3ε (145-2C11),
CD4 (GK1.5), CD8a (53-6.7), CD19 (1D3), CD122 (5H4), NKp46 (29A1.4), IL-6
(MP5-20F3), CD107a (1D4B), and Ki-67 (B56) purchased from BD PharMin-
gen, BioLegend, or eBioscience. For intracellular and intranuclear antigens,
Fix & Perm and Foxp3 staining buffer set (both eBioscience) were used,
respectively. For estimation of total cell number and leukocyte composition,
enzymatic digestion was preferred as it yielded higher amounts of non-lym-
phocytes and did not exclude cells based on size or density. For phenotyping
of NK cells, mechanical dissociation followed by Lympholyte M was used in
order to prevent degradation of surface proteins.
qRT-PCR
From gd10.5 and 9.5 pregnant females, cells of either non-hematopoietic
(CD45), conventional uNK (CD45+, CD3, CD19, NK1.1+, NKp46+,
CD49a) or tissue-resident uNK (CD45+, CD3, CD19, NK1.1+, NKp46+,
CD49a+) phenotype were sorted using a FACSAria III (BD). Cell lysates were
prepared with the Cells-to-CT 1-Step TaqMan Kit (Ambion, Life Technologies)
and mRNA expression was quantified by qRT-PCR using an ABI PRISM
7900HT (Applied Biosystems) using commercially available TaqMan probes2826 Cell Reports 13, 2817–2828, December 29, 2015 ª2015 The Au(Mm00432686_m1, Mm01302427_m1, Mm00434210_m1, Mm00435674_m1
and Mm02619580_g1) for Csf1, Ccl5, Il15, pik3cd, and b-actin, respectively.
Gene expression of each cell type from eachmousewas assessed in triplicate.
Transcript levels were normalized to b-actin using DCT values.
In Vitro Culture
Single-cell suspensions from gd10.5 pregnant females were prepared by Lib-
erase TMdigestion and incubated in complete RPMI cell culturemedia for 2 hr.
Non-adherent cells were removed and cells cultured overnight in fresh
complete RPMI with brefeldin A (eBioscience) and monensin present for the
final 4 hr.
Histology
Rat-antimouseF4/80wasused at 1/100 (C1:A3-1, AbSerotec) after proteinase
Kantigen retrieval and visualized using the ImmPress kit (Vector). Smoothmus-
cle actin (DAKO 1A4) staining was performed after heat-induced antigen
retrieval in citrate buffer using a 1/100 dilution according the instructions of
the mouse-on-mouse immunodetection kit (Vector). Histological examination
of H&E stains for overt placental abnormalities was performed at gd18.5
by determining the area of the labyrinth zone on midsagittal sections through
theplacenta. All histologywascarriedout on formalin-fixedparaffin-embedded
tissue.
Stereology
Tissue volume estimation using the Cavalieri method and assessment of spiral
artery remodeling was performed using H&E-stained sections as described
previously (Kieckbusch et al., 2015).
Cytokine Quantification in Tissue Lysates
Myometrial and decidual tissue from gd10.5 pregnant females was snap
frozen on dry ice and the whole litter pooled. 150 mg tissue was added to
1 ml lysis buffer (150 mM NaCl, 20 mM Tris, 1 mM EGTA, 1% Triton X-100,
1/100 Phosphatase Inhibitor Cocktail 3 [Sigma], 1/100 Phosphatase Inhibitor
II [Sigma], 23 Ultra Protease Inhibitor solution [Roche], and 2 mM PMSF)
and processed with a tissue homogenizer on ice. The homogenate was incu-
bated on ice with agitation for 30 min and spun at 20,000 3 g for 10 min. The
supernatant was used for further analysis on the MesoScale Ultra Sensitive
platform. Total protein concentration was determined using a Bradford assay
(Pierce).
Blood and Serum Measurements
Non-fasting blood samples were taken immediately after cervical dislocation
from the aorta. Blood glucose was measured immediately using a digital gluc-
ometer. Samples were centrifuged at 12,000 3 g for 5 min and supernatant
stored at 80C before being used for MesoScale Ultra Sensitive assays.
Statistics
Normally distributed, independent, and unmatched data were analyzed with
two-tailed, unpaired Student’s t tests. Data clustered by litter (fetal/placental
weights, arterial remodeling) that violate the assumption of independence of
data points were analyzed using a mixed-model approach taking the fixed ef-
fect of parental cross and the random effect of litter variability into account
(Barber and Pollard, 2003; Kieckbusch et al., 2014). Categorical data were
analyzed using Fisher’s exact test. p < 0.05 was taken as statistically signifi-
cant for all tests. Analyses were performed using GraphPad Prism, GraphPad
Quick Calcs, and IBM SPSS.
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